HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nak-Won Sohn Selected Research

Potassium

8/2004Neuroprotective effect of KR-31378 via KATP channel opening against ischemic insult.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nak-Won Sohn Research Topics

Disease

4Memory Disorders (Memory Loss)
01/2018 - 12/2013
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 12/2013
3Neuroinflammatory Diseases
12/2013 - 01/2012
2Cognitive Dysfunction
01/2018 - 01/2015
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 12/2013
2Spinal Cord Injuries (Spinal Cord Injury)
01/2017 - 01/2013
2Inflammation (Inflammations)
01/2013 - 02/2010
2Common Cold
12/2011 - 02/2010
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2018
1Tauopathies
01/2017
1Spinal Cord Compression
01/2013
1Edema (Dropsy)
01/2012
1Hematoma
01/2012
1Hemorrhage
01/2012
1Arthritis (Polyarthritis)
12/2011
1Necrosis
08/2010
1Dermatitis
02/2010
1Psoriasis (Pustulosis Palmaris et Plantaris)
02/2010
1Autoimmune Diseases (Autoimmune Disease)
02/2010
1Hypersensitivity (Allergy)
06/2009
1Infections
05/2009
1Liver Diseases (Liver Disease)
05/2009
1Constipation
01/2009
1Stroke (Strokes)
01/2009
1Brain Edema (Cerebral Edema)
01/2009
1Erectile Dysfunction
08/2007
1Ischemia
08/2004
1Brain Ischemia (Cerebral Ischemia)
08/2004
1Neuroblastoma
08/2004

Drug/Important Bio-Agent (IBA)

4LipopolysaccharidesIBA
01/2014 - 08/2010
3Neuroprotective AgentsIBA
01/2017 - 08/2004
2Pharmaceutical PreparationsIBA
01/2018 - 12/2013
2AntioxidantsIBA
01/2017 - 01/2015
2ginsenoside Rg3IBA
01/2017 - 01/2012
2CytokinesIBA
01/2014 - 01/2013
1Amyloid (Amyloid Fibrils)IBA
01/2018
1scutellarinIBA
01/2018
1nobiletinIBA
01/2017
1tau Proteins (tau Protein)IBA
01/2017
1astragaloside AIBA
01/2015
1asaroneIBA
01/2014
1Messenger RNA (mRNA)IBA
01/2014
1Glycyrrhizic Acid (Glycyrrhizin)IBA
12/2013
1ginsenoside Rb1IBA
09/2013
1tetramethylpyrazineIBA
01/2013
1Thymidine Monophosphate (TMP)IBA
01/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2012
1Evans Blue (Blue, Evans)FDA Link
01/2012
1NF-KappaB Inhibitor alphaIBA
08/2010
1Protein Kinases (Protein Kinase)IBA
08/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2010
1Interleukin-6 (Interleukin 6)IBA
08/2010
1JNK Mitogen-Activated Protein KinasesIBA
08/2010
1Interleukin-4 (Interleukin 4)IBA
02/2010
1Immunoglobulin E (IgE)IBA
06/2009
1Phosphotransferases (Kinase)IBA
06/2009
1OvalbuminIBA
06/2009
1NF-kappa B (NF-kB)IBA
06/2009
1Interleukin-12 (IL 12)IBA
06/2009
1shosaiko-to (TJ9)IBA
05/2009
1AphrodisiacsIBA
08/2007
1N''- cyano- N- (6- amino- 3,4- dihydro- 3- hydroxy- 2- methyl- 2- dimethoxymethyl- 2H- benzopyran- 4- yl)- N'- benzylguanidineIBA
08/2004
1PotassiumIBA
08/2004
1Oxygen (Dioxygen)IBA
08/2004
1KATP ChannelsIBA
08/2004
1Glucose (Dextrose)FDA LinkGeneric
08/2004
1Adenosine Triphosphate (ATP)IBA
08/2004

Therapy/Procedure

2East Asian Traditional Medicine (Oriental Medicine)
02/2010 - 01/2009
1Traditional Medicine (Folk Remedies)
12/2011